Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
784.00    -6.00 (-0.76%)
Bid:
780.00
Ask:
796.00
Spread: 16.00 (2.051%)
Market Cap: £361.39m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

AGM/Interim Management Statement

13 Apr 2010 07:00

RNS Number : 0520K
Porvair PLC
13 April 2010
 



FOR IMMEDIATE RELEASE

13 April 2010

 

Porvair plc

AGM Statement and Interim Management Statement

 

Porvair plc ("Porvair"), the specialist filtration and environmental technology group will today, 13 April 2010, make the following Interim Management Statement at its Annual General Meeting:

 

Porvair has made an encouraging start to the 2010 financial year. In the four months to 31 March 2010, profit before tax is well ahead of the prior year. Current net borrowings are £3.3m lower than the equivalent time last year. At constant exchange rates, revenues are around 5% higher than the prior period, with recovery or continued growth in most markets offset by expected modest declines in aerospace filtration sales.

 

In the Metals Filtration division sales revenues are 13% higher than the prior period. This business has a lower cost base following its 2009 restructuring and as a result profitability is better. It should be noted that whilst levels of demand in 2010 have improved, they remain below those of 2004-2008 and management continue to look at projects that will boost the underlying performance of this division. Key to this will be the sustained success of new products, which continue to go well. 85% of the division's aluminium customers have now converted to the patented Selee CS-X™ filter. Upgrades have been introduced in recent weeks that further enhance this market leading product in the aluminium industry. In the iron foundry industry, a similarly exciting new product, the patented Selee IC™ filter, has now been adopted by several leading automotive and agricultural machinery manufacturers in the US.

 

In the Microfiltration division sales revenues are slightly ahead of the prior year. Seal Analytical has made a strong start with improved sales in the US and Europe and continuing strength in Asia helped by the introduction of the Seal Analytical AQ1™ water analyser in February 2010. The division is seeing satisfactory levels of demand in energy and nuclear filtration where several larger orders are scheduled for delivery later in the year. Growth in this division's US industrial filtration business has been robust. This is offset by a decline in aerospace schedules compared with a strong opening quarter of the prior year. Aerospace sales in 2010 are at similar levels to the second half of 2009 with run rates and order schedules showing modest improvements over the last three months.

 

The Company will be announcing its interim results for the six months ending 31 May 2010 on Tuesday 29 June 2010.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Catherine Breen

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSFLFLEFSSEDL
Date   Source Headline
9th Dec 20217:00 amRNSPre-close trading update and Notice of Results
23rd Nov 202112:30 pmRNSHolding(s) in Company
5th Nov 20214:40 pmRNSSecond Price Monitoring Extn
5th Nov 20214:35 pmRNSPrice Monitoring Extension
8th Oct 20214:40 pmRNSSecond Price Monitoring Extn
8th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Sep 20214:41 pmRNSSecond Price Monitoring Extn
27th Sep 20214:35 pmRNSPrice Monitoring Extension
16th Sep 20213:31 pmRNSDirector/PDMR Shareholding
14th Sep 20217:00 amRNSNine Month Trading Update
11th Aug 20214:41 pmRNSSecond Price Monitoring Extn
11th Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 20214:40 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20217:00 amRNSBlock listing Interim Review
5th Jul 20217:00 amRNSHalf Year Results 2021
30th Jun 20217:00 amRNSTotal Voting Rights
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:35 pmRNSPrice Monitoring Extension
10th May 20214:40 pmRNSSecond Price Monitoring Extn
10th May 20214:36 pmRNSPrice Monitoring Extension
21st Apr 20212:40 pmRNSGrant of LTSP awards
20th Apr 202112:30 pmRNSAGM resolutions and Board changes
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 20214:28 pmRNSTotal Voting Rights
17th Mar 20214:57 pmRNSHolding(s) in Company
16th Mar 20212:01 pmRNSHolding(s) in Company
2nd Mar 20214:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20213:27 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSAcquisition of Kbiosystems Limited
22nd Feb 20213:00 pmRNSHolding(s) in Company
19th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 20214:36 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSBlock listing Interim Review
8th Feb 20217:00 amRNSTotal Voting Rights
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
3rd Feb 20219:42 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSGrant of LTSP awards
1st Feb 20217:00 amRNSFinal Results
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:35 pmRNSPrice Monitoring Extension
30th Dec 20203:30 pmRNSHolding(s) in Company
30th Dec 20203:30 pmRNSHolding(s) in Company
9th Dec 20203:47 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSPre-close trading update
23rd Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.